MedTrace Logo

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

NCT02545101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-03-07

Study results available
· View outcomes & findings →

Summary

This is a retrospective chart review non-interventional study designed to collect real world data on the use and outcomes of tolvaptan for the treatment of patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone (SIADH) secretion.

Conditions

  • Hyponatremia
  • Syndrome of Inappropriate ADH (SIADH) Secretion

Sponsors & Collaborators

  • Otsuka Pharmaceutical Europe Ltd

    lead INDUSTRY

Principal Investigators

  • Medical Department · Otsuka Europe

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Germany
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545101 on ClinicalTrials.gov